C1q Antibody (Monoclonal) , Biotinylated

A biotin conjugated murine monoclonal antibody to an epitope on the globular head domain of C1q.


Product Specifications

Citations3
Clonality

Monoclonal

Immnogen

Purified human protein.

Applications

See citations and technical data sheet for application info.

Concentration0.2 mg/mL
ConjugateBiotin
Cross Reactivity

Human

Ordering Information

For Research Use Only in the United States. Not for use in diagnostic procedures.
Catalog NumberA700
Catalog Number (CE)N/A
Size250 µL
Price (USD)$365.00
Price (EURO)330,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

A biotin conjugated murine monoclonal antibody to an epitope on the globular head domain of C1q.

Size

250 µL

Concentration0.2 mg/mL
ApplicationsSee citations and technical data sheet for application info.
FormLiquid. Phosphate Buffered Saline (pH 7.0 ± 0.2), 1% Bovine Serum Albumin, with ≤ 0.1% Sodium Azide.
ClonalityMonoclonal
Immunogen

Purified human protein.

ConjugateBiotin
Cross ReactivityHuman
Isotype

IgG1k

Purity

≥ 95% by SDS Page

SourceMouse
Specificity

This monoclonal antibody was raised against purified human C1q Protein. It is specific for the globular head domain.

Storage

Short term (30 days) 4˚C. Long term at or below –20˚C.

Background

Circulating C1q protein is a hexamer of three unique protein subunits (A,B, and C) with molecular weights of 29, 26 and 22 kD respectively. The assembled hexamer contains a central core or stalk, six collagen-like domains and six globular protein heads. These globular or terminal regions are responsible for the binding of immunoglobulin (IgM,and IgG). As part of the C1 complex (together with two copies each of C1r and C1s) C1q is central to activation of the classical complement pathway. The specificity of this monoclonal to purified human C1q was determined Quidel’s monoclonal antibodies to complement antigens were prepared using standard techniques. They are purified from mouse ascites fluid via protein A affinity chromatography. Quidel’s Monoclonal anti human C1q was raised against highly pure, human C1q using standard techniques. The specificity of the monoclonal antibody was established via a series of immunoassays utilizing highly purified C1q and C1q fragments. Firstly, the antibody was shown by ELISA to bind to purified C1q and C1q globular head protein immobilized in microtiter wells. Secondly, free (unbound) C1q and globular head and human serum but not other C1q fragments were shown (via inhibition EIA) to inhibit the binding of this antibody to immobilized C1q. Similarly, using radio-labeled C1q this antibody was shown to immuno-precipitate C1q using protein A-bearing bacteria.